financetom
Business
financetom
/
Business
/
WillScot Holdings Q2 Adjusted Earnings Decline, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
WillScot Holdings Q2 Adjusted Earnings Decline, Revenue Rises
Aug 2, 2024 1:01 AM

03:36 AM EDT, 08/02/2024 (MT Newswires) -- WillScot Holdings ( WSC ) reported Q2 adjusted earnings late Thursday of $0.39 per diluted share, down from $0.44 a year earlier.

Analysts polled by Capital IQ expected $0.42.

Revenue for the quarter ended June 30 was $604.6 million, up from $582.1 million a year earlier. Analysts surveyed by Capital IQ expected $613.4 million.

For 2024, the company expects revenue to be in a range of $2.4 billion to $2.5 billion, excluding its pending acquisition of McGrath (MGRC). The previous outlook in May was for revenue to be between $2.49 billion to $2.64 billion.

Analysts polled by Capital IQ expect $2.49 billion in revenue for the year.

Price: 38.00, Change: -1.81, Percent Change: -4.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal
Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal
Apr 20, 2026
10:15 AM EDT, 04/20/2026 (MT Newswires) -- Sila Realty Trust ( SILA ) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion. Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's...
Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility
Arcus Biosciences Discontinues Phase 3 Lung Cancer Trial for Futility
Apr 20, 2026
10:16 AM EDT, 04/20/2026 (MT Newswires) -- Arcus Biosciences ( RCUS ) said Monday it discontinued its phase 3 STAR-121 study in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee recommended stopping the trial for futility. The study, conducted in collaboration with Gilead Sciences ( GILD ) , evaluated domvanalimab plus zimberelimab and chemotherapy versus pembrolizumab plus...
Phillips 66, Kinder Morgan move ahead with new US West Coast fuel pipeline
Phillips 66, Kinder Morgan move ahead with new US West Coast fuel pipeline
Apr 20, 2026
April 20 (Reuters) - Phillips 66 and Kinder Morgan ( KMI ) have secured enough long-term shipper commitments to move forward with a proposed pipeline project to supply fuel to Arizona and California, they said on Monday. The Western Gateway Pipeline project comes as companies race to build a major new fuel pipeline to the U.S. West Coast ahead of...
Cleveland-Cliffs Beats First-Quarter Forecasts as Loss Narrows; CEO Signals Profit Ahead
Cleveland-Cliffs Beats First-Quarter Forecasts as Loss Narrows; CEO Signals Profit Ahead
Apr 20, 2026
10:43 AM EDT, 04/20/2026 (MT Newswires) -- Cleveland-Cliffs ( CLF ) first-quarter loss narrowed more than expected with revenue exceeding market estimates, while CEO Lourenco Goncalves said the steel producer anticipates a return to profit in the second quarter. The company said Monday its adjusted loss narrowed to $0.40 a share in the March quarter from the loss of $0.93...
Copyright 2023-2026 - www.financetom.com All Rights Reserved